RxDoctor Payments Data

Nicole Karjane, MD

Obstetrics & Gynecology · Richmond, VANPI 1942390646

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,856 of the $34,106 with a category attached, or 96.3%. Organon accounts for 77.9% of it on its own, with 5 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,106in general payments, 2019–2025

Across 49 payments — averaging $696.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$27K
  • Merck$7K
  • Hologic Sales And Service, LLC$159
  • Davol Inc.$37
  • AMAG Pharmaceuticals, Inc.$25
  • Exeltis, USA Inc.$12

What the payments were for

  • Speaking & faculty fees$32,85696%
  • Travel & lodging$3651%
  • Food & beverage$8613%
  • Education$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,106 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$2,713
Medicare patients
21
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized14$405
Estradiol11$85

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →